PROT < sub > 3 < /sub > EcT, engineered Escherichia coli for the targeted delivery of therapeutics

Trends Mol Med. 2023 Aug 11:S1471-4914(23)00157-0. doi: 10.1016/j.molmed.2023.07.007. Online ahead of print.NO ABSTRACTPMID:37574350 | DOI:10.1016/j.molmed.2023.07.007

Source: Trends in Molecular Medicine - August 13, 2023 Category: Molecular Biology Authors: Coral Gonz ález-Prieto Jason P Lynch Cammie F Lesser Source Type: research